7 March 2025
Spire Healthcare Group plc (the "Company" or "Spire Healthcare")
Acquisition of Spire Healthcare shares
The Company reports that Peter White, PCA of Debbie White, Spire's Senior Independent Director, has purchased ordinary shares in the Company as follows:
| Person Closely Associated (PCA) | Shares purchased | Date of purchase | Price | Holding post announcement |
| Peter White | 26,316 | 6 March 2025 | 189.007 pence | 26,316 |
Enquiries:
Amie Gramlick, Director of Investor Relations investors@spirehealthcare.com
Notification and public disclosure of transaction by persons discharging managerial responsibility and persons closely associated with them
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name
| Peter White | |
| 2 | Reason for the notification | ||
| a) | Position/status
| PCA of Debbie White, Spire's Senior Independent Director | |
| b) | Initial notification /Amendment
| Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name
| Spire Healthcare Group plc | |
| b) | LEI | 213800IBJPW3SE2RA350 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1 pence each
GB00BNLPYF73 | |
| b) | Nature of the transaction | Purchase of 26,316 ordinary shares at 189.007 pence each | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| 189.007 pence | 26,316 | ||
|
| |||
| d) | Aggregated information - Aggregated volume - Price | As above | |
| e) | Date of the transaction | 2025-03-06 | |
| f) | Place of the transaction | XLON | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.